CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells

被引:17
作者
Lian, Haiwei [1 ,2 ,3 ]
Li, Dun [2 ,4 ]
Zhou, Yun [2 ,5 ]
Landesman-Bollag, Esther [4 ]
Zhang, Guanglan [6 ]
Anderson, Nicole M. [2 ]
Tang, Kevin Charles [2 ]
Roderick, Justine E. [7 ]
Kelliher, Michelle A. [7 ]
Seldin, David C. [4 ]
Fu, Hui [1 ]
Feng, Hui [2 ,4 ]
机构
[1] Wuhan Univ, Sch Basic Med Sci, Dept Anat & Embryol, Wuhan, Hubei, Peoples R China
[2] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02215 USA
[3] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China
[4] Boston Univ, Sch Med, Dept Med, Sect Hematol & Med Oncol, Boston, MA 02215 USA
[5] Wuhan Univ, Renmin Hosp, Dept Gynaecol, Wuhan, Hubei, Peoples R China
[6] Boston Univ, Metropolitan Coll, Dept Comp Sci, Boston, MA 02215 USA
[7] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA
关键词
PATHWAY; MYC; RESISTANCE; THERAPY; GROWTH;
D O I
10.3324/haematol.2016.154013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E17 / E21
页数:5
相关论文
共 15 条
[1]   Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling [J].
Buontempo, F. ;
Orsini, E. ;
Martins, L. R. ;
Antunes, I. ;
Lonetti, A. ;
Chiarini, F. ;
Tabellini, G. ;
Evangelisti, C. ;
Evangelisti, C. ;
Melchionda, F. ;
Pession, A. ;
Bertaina, A. ;
Locatelli, F. ;
McCubrey, J. A. ;
Cappellini, A. ;
Barata, J. T. ;
Martelli, A. M. .
LEUKEMIA, 2014, 28 (03) :543-553
[2]   AIP4/Itch Regulates Notch Receptor Degradation in the Absence of Ligand [J].
Chastagner, Patricia ;
Israel, Alain ;
Brou, Christel .
PLOS ONE, 2008, 3 (07)
[3]   Protein kinase CK2 phosphorylates and upregulates Akt/PKB [J].
Di Maira, G ;
Salvi, M ;
Arrigoni, G ;
Marin, O ;
Sarno, S ;
Brustolon, F ;
Pinna, LA ;
Ruzzene, M .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (06) :668-677
[4]   ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth [J].
Hart, Lori S. ;
Cunningham, John T. ;
Datta, Tatini ;
Dey, Souvik ;
Tameire, Feven ;
Lehman, Stacey L. ;
Qiu, Bo ;
Zhang, Haiyan ;
Cerniglia, George ;
Bi, Meixia ;
Li, Yan ;
Gao, Yan ;
Liu, Huayi ;
Li, Changhong ;
Maity, Amit ;
Thomas-Tikhonenko, Andrei ;
Perl, Alexander E. ;
Koong, Albert ;
Fuchs, Serge Y. ;
Diehl, J. Alan ;
Mills, Ian G. ;
Ruggero, Davide ;
Koumenis, Constantinos .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (12) :4621-4634
[5]   An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia [J].
Knoechel, Birgit ;
Roderick, Justine E. ;
Williamson, Kaylyn E. ;
Zhu, Jiang ;
Lohr, Jens G. ;
Cotton, Matthew J. ;
Gillespie, Shawn M. ;
Fernandez, Daniel ;
Ku, Manching ;
Wang, Hongfang ;
Piccioni, Federica ;
Silver, Serena J. ;
Jain, Mohit ;
Pearson, Daniel ;
Kluk, Michael J. ;
Ott, Christopher J. ;
Shultz, Leonard D. ;
Brehm, Michael A. ;
Greiner, Dale L. ;
Gutierrez, Alejandro ;
Stegmaier, Kimberly ;
Kung, Andrew L. ;
Root, David E. ;
Bradner, James E. ;
Aster, Jon C. ;
Kelliher, Michelle A. ;
Bernstein, Bradley E. .
NATURE GENETICS, 2014, 46 (04) :364-+
[6]   Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study [J].
Ko, Richard H. ;
Ji, Lingyun ;
Barnette, Phillip ;
Bostrom, Bruce ;
Hutchinson, Raymond ;
Raetz, Elizabeth ;
Seibel, Nita L. ;
Twist, Clare J. ;
Eckroth, Elena ;
Sposto, Richard ;
Gaynon, Paul S. ;
Loh, Mignon L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :648-654
[7]   T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) [J].
Marks, David I. ;
Paietta, Elisabeth M. ;
Moorman, Anthony V. ;
Richards, Susan M. ;
Buck, Georgina ;
DeWald, Gordon ;
Ferrando, Adolfo ;
Fielding, Adele K. ;
Goldstone, Anthony H. ;
Ketterling, Rhett P. ;
Litzow, Mark R. ;
Luger, Selina M. ;
McMillan, Andrew K. ;
Mansour, Marc R. ;
Rowe, Jacob M. ;
Tallman, Martin S. ;
Lazarus, Hillard M. .
BLOOD, 2009, 114 (25) :5136-5145
[8]   FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors [J].
O'Neil, Jennifer ;
Grim, Jonathan ;
Strack, Peter ;
Rao, Sudhir ;
Tibbitts, Deanne ;
Winter, Christopher ;
Hardwick, James ;
Welcker, Markus ;
Meijerink, Jules P. ;
Pieters, Rob ;
Draetta, Giulio ;
Sears, Rosalie ;
Clurman, Bruce E. ;
Look, A. Thomas .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1813-1824
[9]   Oncogenic NOTCH1 control of MYC and PI3K: Challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas [J].
Palomero, Teresa ;
Ferrando, Adolfo .
CLINICAL CANCER RESEARCH, 2008, 14 (17) :5314-5317
[10]   Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells [J].
Park, Hae Sun ;
Jun, Do Youn ;
Han, Cho Rong ;
Woo, Hyun Ju ;
Kim, Young Ho .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (09) :1110-1125